Vol 11, Supplement 3 (March 12, 2019): Journal of Thoracic Disease


Risk factors for chylothorax after esophagectomy
Naoya Yoshida, Hideo Baba
Clinical manifestation, risk factors and managements for postoperative chylothorax after thoracic esophagectomy
Takeo Fujita, Takuji Sato, Kazuma Sato, Yuki Hirano, Hisashi Fujiwara, Hiroyuki Daiko
Preoperative stratification for postoperative delirium: obstructive sleep apnea is a predictor, the STOP-BANG is not?
Federico Bilotta, Giovanni Giordano, Francesco Pugliese
How can we reduce the incidence of postoperative mental disorders after thoracic surgery?
Satoshi Shiono
How complement activation via a C3a receptor pathway alters CD4+ T lymphocytes and mediates lung cancer progression? —future perspectives
Marcos Magalhães Filho, Pedro Nazareth Aguiar Junior, Jacob J. Adashek, Ramon Andrade De Mello
Catheter ablation: an ongoing revolution
Alexandre Raymond-Paquin, Jason Andrade, Laurent Macle
Prioritizing mutational profiling for targeted therapy of lung adenocarcinoma
Ansam Sinjab, Arafat Tfayli
Non-intubated uniportal video-assisted thoracoscopic surgery
Hussein Elkhayat, Diego Gonzalez-Rivas
Impact of dedicated perioperative care in neonatal cardiac surgery
Pierre-Emmanuel Séguéla, Zakaria Jalal, Jean-Benoit Thambo
Oxygen: a powerful drug to handle with care
Irene Coloretti, Martina Tosi, Emanuela Biagioni, Massimo Girardis
The message from the matrix—should we listen more closely?
Janette K. Burgess, Markus Weckmann, Morten A. Karsdal
Lung volume reduction surgery in patients with low diffusion capacity
Helen Weaver, Neil J. Greening, Sridhar Rathinam
Lung-protective ventilation during one-lung ventilation: known knowns, and known unknowns
Xiao-Yun Hu, Bin Du
The pretreatment circulating albumin-to-fibrinogen ratio in patients with non-small cell lung cancer: a simple, economical, and effective biomarker
Kazutoshi Hamanaka, Kentaro Miura, Tsutomu Koyama, Shunichiro Matsuoka, Tetsu Takeda, Kyoko Yamada, Akira Hyogotani
Non-coding RNAs in lung cancer
Esen Tutar, Yusuf Tutar
Osimertinib for EGFR-mutant non-small cell lung cancer: place in therapy and future perspectives
Biagio Ricciuti
Expression of miR-630 associated with tyrosine kinase inhibitor therapeutic response in lung adenocarcinoma cases
Srijit Das
Spread through air spaces in lung adenocarcinoma: is radiology reliable yet?
Roberta E. Ledda, Gianluca Milanese, Letizia Gnetti, Andrea Borghesi, Nicola Sverzellati, Mario Silva
Hyperprogressive disease: a distinct effect of immunotherapy?
Vinita Popat, David E. Gerber
Do the right thing!
Marco Anile, Camilla Poggi, Daniele Diso, Sara Mantovani, Massimilano Bassi, Erino A. Rendina, Federico Venuta
How does Surgical Apgar Score predict the short-term complications and long-term prognosis after esophagectomy?
Wei-Peng Hu, Yu-Shang Yang, Yong Yuan, Wen-Ping Wang, Qi-Xin Shang, Long-Qi Chen
Stereotactic body radiation therapy and surgery for early lung cancer “two sides of the same coin”
Giuseppe Parisi, Tino Ceschia, Alessandro Parisi
Editorial on comparison between stereotactic body radiotherapy and surgery in early stage NCSLC by Scotti et al.
Hideomi Yamashita
Comparison of pulmonary metastasectomy and stereotactic body radiation therapy for the treatment of lung metastases
Francesco Petrella, Lorenzo Spaggiari
Editorial on “Trans-inferior-pulmonary-ligament VATS basal segmentectomy: application of single-direction strategy in segmentectomy of left S9+10”
Alberto Lopez-Pastorini, Erich Stoelben, Aris Koryllos
Percutaneous mitral valve repair: an evolving reality
Rodrigo Mendirichaga, Vikas Singh
The impact of insight on post-lobectomy complications
Kareem Ibrahim, Bryan M. Burt
Does the “obesity paradox” really exist in lung cancer surgery? —maybe we should recognize what is the “obesity” first
Shuangjiang Li, Guowei Che, Lunxu Liu, Longqi Chen
Targeted treatment of acute respiratory distress syndrome with statins—a commentary on two phenotype stratified re-analysis of randomized controlled trials
Nanon F. L. Heijnen, Dennis C. J. J. Bergmans, Ronny M. Schnabel, Lieuwe D. J. Bos, on behalf of the DARTS consortium
“No option” patients for coronary revascularization: the only thing that is constant is change
Leor Perl, Ran Kornowski
Acute respiratory distress syndrome phenotyping and latent class analysis, first steps toward precision medicine in critical care illness?
Christophe Guervilly, Gabriel Parzy, Laurent Papazian
Role of surface electrocardiogram in the era of high-resolution mapping and imaging systems—back to the future
Carlo Lavalle, Marco Valerio Mariani, Domenico Giovanni Della Rocca, Andrea Natale
The multidisciplinary lung cancer team meeting: increasing evidence that it should be considered a medical intervention in its own right
Chris Dickhoff, Max Dahele
Is simulation the only keystone of surgical training?
Leonardo Teodonio, Claudio Andreetti, Alberto Emiliano Baccarini, Mohsen Ibrahim
Hippo pathway as another oncogenic mediator to promote immune evasion by PD-L1 signaling
Sook-Hee Hong
Robotic lobectomy has the greatest benefit in patients with marginal pulmonary function
Monica Casiraghi, Lorenzo Spaggiari
Sepsis: early interventions count but not RRT!
Sebastian J. Klein, Michael Joannidis, Lui Forni
Immunoescape the link between emphysema and lung cancer?
Jaume Sauleda, Francisco Javier Verdú, Sergio Scrimini, Ernest Sala, Jaume Pons
Lymph node metastasis matters
Haruhiko Sugimura, Katsuhiro Yoshimura
Is the prognostic nutritional index (PNI) a useful predictive marker for postoperative complications after lung surgery?
Xin Li, Jun Chen
Prophylactic cranial irradiation in non-small cell lung cancer: the debate is open
Carlo Greco, Antonio Rossi, Sara Ramella
Protective intraoperative ventilation during thoracic surgery: definitively yes!
Laura Pasin
Optimizing intraoperative ventilation during one-lung ventilation—is individualization the road to success?
Felix F. Girrbach, Uta C. Pietsch, Hermann Wrigge
The ABCs of preventing hyperprogressive disease after immunotherapy: awareness, biomarkers, and combination
Kenichi Suda
Significance of chest ultrasound in the early postoperative period following thoracic surgery
Thomas G. Lesser
The relativity of operative time on the outcomes of the video-assisted thoracoscopic lobectomies
Luca Bertolaccini, Francesca Calabrese, Kenji Kawamukai, Jury Brandolini, Piergiorgio Solli
Preoperative resting heart rate: a novel risk factor for cardiopulmonary complications after lung resection
Xiaoshuang Zhou, Wanyu Wang, Lili Huang, Bin Liu
The importance of asking the right questions: the role of chest ultrasound in thoracic surgery
Miriam Patella, Francesco Mongelli, Stefano Cafarotti
The obesity paradox in lung cancer: is there a missing biological link?
Konstantinos Mavridis, Kleita Michaelidou
The del Nido cardioplegia in adult cardiac surgery: reinventing myocardial protection?
Wenzong Luo, Ismail Bouhout, Philippe Demers
Ultimate management of post thoracotomy morbidities: a set of surgical technique and peri-operative precautions
Federico Raveglia, Marco Scarci, Ugo Cioffi, Alessandro Baisi
Immuno-checkpoint inhibitors in metastatic esophago-gastric cancer
Marina Schena, Angelo F. Battaglia, Antonio Trogu
Could WNT inhibitors really knock on the treatment door of small cell lung cancer?
Laura Esteller, Susana Hernández, Fernando Lopez-Rios, Jordi Remon
Second-generation drug-eluting stents versus bare-metal stents in saphenous vein grafts: is the choice more complicated than before?
Mariano Pellicano, Alessia Azzano, Emanuele Barbato
Evolving definition of acute respiratory distress syndrome
Jeremy Bourenne, Julien Carvelli, Laurent Papazian
CheckMate-032 Study: promising efficacy with nivolumab-based immunotherapy in pretreated esophagogastric cancer
Der Sheng Sun, Jae Jun Kim, Yoon Ho Ko
PD1/PD-L1 inhibitor treatment for late stage non-small cell lung carcinoma, sometimes…does more harm than good!
Paul Hofman
Drug eluting stents versus bare metal stents for the treatment of saphenous vein grafts failure: learnings from the DIVA trial
Neila Sayah, Gregoire Lefèvre, Fabien Picard
Predictor of cardiopulmonary complication after pulmonary resection
Keisuke Asakura
Clinical impact of preoperative immunonutritional status in patients undergoing surgical resection of lung cancer
Fumihiro Shoji
Lung transplantation and beyond: continued challenges in the wake of significant progress
Norihisa Shigemura
Treatment of ipsilateral shoulder pain after thoracic surgery—time for comparative studies?
Morten Rune Blichfeldt-Eckhardt, Palle Toft
The significance of pulmonary fissure completeness in video-assisted thoracoscopic surgery
Seokkee Lee, Jin Gu Lee
Improving lung cancer diagnosis: the evolving role of patients and care providers
Mike R. Sung, Natasha B. Leighl
Is it worth to apply extra-corporeal membrane oxygenation in the immunocompromised patients with severe acute respiratory distress syndrome?
Carmen Silvia Valente Barbas, Gustavo Faissol Janot de Matos
KEYNOTE-024: goodbye to chemotherapy?
Rossana Berardi
The time for lipoprotein(a) based intervention has arrived: where will the light shine?
Stephen J. Nicholls, Adam J. Nelson
Can hybrid procedure eliminate the gaps of experience in surgical ablation for atrial fibrillation and improve the sinus rhythm maintenance?
Chin-Yu Lin, Yenn-Jiang Lin, Shih-Ann Chen
Is wall shear stress ready to become a prime-time clinical tool?—measurement of post-surgical patterns in patients undergoing aortic valve and thoracic aortic replacement using 4-dimensional flow magnetic resonance imaging
Matheus G. Carelli, Michael Seco, Paul G. Bannon, Stuart M. Grieve
Sarcopenia is a potential factor for optimized treatment selection for elderly patients with early stage non-small cell lung cancer
Yukinori Matsuo
Optimal mode of aortic valve replacement in patients with chronic obstructive pulmonary disease-which helps patients gain more benefit?
Wen-Yu Lv, Shuang-Jiang Li, Mao Chen
The role of osimertinib in epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer
Chong-Kin Liam
cT2N0 esophageal adenocarcinoma: predictors of lymph nodal involvement and clinical significance
Saurabh Singhal, Soumen Roy
Recent evidence on delamanid use for rifampicin-resistant tuberculosis
Emanuele Pontali, Rosella Centis, Lia D’Ambrosio, Federica Toscanini, Giovanni Battista Migliori
In vivo experimental models account for higher complexity than in vitro preclinical settings in cancer
Giovanni Blandino, Federica Lo Sardo
On rough road of hypoplastic left heart syndrome after Norwood procedure
Chiara Marrone, Lorenzo Galletti
Advantages associated with the use of a wound retractor compared to a rigid trocar inserted via the camera port during video-assisted thoracic surgery
Mitsuhiro Kamiyoshihara, Hitoshi Igai, Ryohei Yoshikawa, Fumi Ohsawa, Tomohiro Yazawa

Letter to the Editor

Correspondence regarding “Is the prognostic nutritional index (PNI) a useful predictive marker for postoperative complications after lung surgery?” by Dr. X Li and J Chen
Masayoshi Inoue, Satoru Okada
Can we assess which is better?—transcatheter or surgical aortic valve replacement in intermediate or lower risk patients with chronic obstructive pulmonary disease
Tomo Ando, Hisato Takagi
A reply to “Aligning airway management strategy with resuscitation priorities for out-of-hospital cardiac arrest” by Burjek et al.
Jestin N. Carlson, Mohamud R. Daya, Henry E. Wang
The bar that gave me my life back
Sivakumar Krishnasamy, Ee Phui Kew, Ehab Bishay
Comment to the Editorial by KS Park and EW Kang “Is only fixed positive airway pressure a robust tool for kidney protection in patients with obstructive sleep apnea?”
Oreste Marrone, Fabio Cibella, Jean-Louis Pépin, Ludger Grote, Johan Verbraecken, Tarja Saaresranta, John A. Kvamme, Ozen K. Basoglu, Carolina Lombardi, Walter T. McNicholas, Jan Hedner, Maria R. Bonsignore, on behalf of the ESADA network
Role of skeletal muscle on chest computed tomography for risk stratification of lung cancer patients
Amelie S. Troschel, Fabian M. Troschel, Ashok Muniappan, Henning A. Gaissert, Florian J. Fintelmann


The supplement was commissioned by the Editorial office, Journal of Thoracic Disease without any sponsorship or funding.